Australian Launch of the MND MAGNET Trial
MAGNET (Multi-arm, Adaptive, Group-sequential trial NETwork) is an international platform trial innovated to streamline the evaluation of potential motor neuron disease (MND) treatments.
The idea of a platform trial is that multiple treatments can be tested simultaneously, and more people are randomized into treatment arms rather than placebo.
MAGNET’s first sub-study evaluates the efficacy of lithium carbonate in MND patients who have a specific mutation in the UNC13A gene.